Cogent Biosciences (COGT) Net Income (2017 - 2020)
Historic Net Income for Cogent Biosciences (COGT) over the last 4 years, with Q4 2020 value amounting to -$11.4 million.
- Cogent Biosciences' Net Income fell 59478.49% to -$11.4 million in Q4 2020 from the same period last year, while for Sep 2021 it was -$11.4 million, marking a year-over-year increase of 8334.77%. This contributed to the annual value of -$321.7 million for FY2025, which is N/A changed from last year.
- As of Q4 2020, Cogent Biosciences' Net Income stood at -$11.4 million, which was down 59478.49% from -$57.2 million recorded in Q3 2020.
- Cogent Biosciences' Net Income's 5-year high stood at $2.3 million during Q4 2019, with a 5-year trough of -$57.2 million in Q3 2020.
- Over the past 4 years, Cogent Biosciences' median Net Income value was -$8.0 million (recorded in 2018), while the average stood at -$10.9 million.
- Its Net Income has fluctuated over the past 5 years, first soared by 12676.83% in 2019, then crashed by 59478.49% in 2020.
- Quarter analysis of 4 years shows Cogent Biosciences' Net Income stood at -$6.8 million in 2017, then decreased by 26.77% to -$8.6 million in 2018, then skyrocketed by 126.77% to $2.3 million in 2019, then plummeted by 594.78% to -$11.4 million in 2020.
- Its last three reported values are -$11.4 million in Q4 2020, -$57.2 million for Q3 2020, and -$7.4 million during Q2 2020.